Press release
Gastrointestinal Drugs Market Perceive Accruals USD 59.3 Billion – Avail at MRFR
Gastrointestinal Drugs Market
Gastrointestinal Drugs Market Scenario:
Gastrointestinal (GI) diseases affects stomach, large intestine and rectum, small intestine, esophagus, liver, gallbladder and pancreas. The symptoms of GI diseases are heartburn, indigestion, bloating, constipation and many more.
According to a report by the World Gastroenterology Organization, 35-40 % of world’s total population is suffering from acute or chronic GI complication. Increasing patient having GI diseases and disorders, due to change in dietary pattern are the major factor for increasing the global GI drug market.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/558
The exact cause for inflammatory bowel disease and Irritable bowel syndrome are still unknown due to which permanent cure for this disease is not available which may restrain the growth of the market.
The global gastrointestinal drug market is expected to grow at CAGR of 4.8% during forecasted period 2017- 2023. It is estimated to reach till USD $ 59.3 billion by end of 2024
Gastrointestinal Drugs Market Segmentation:
Global Gastrointestinal Drugs market has been segmented on the basis of Drug Category they are segmented into Acid Neutralizers, Laxatives and Antidiarrheal, antiemetic, Anti-inflammatory drugs and other. By Route of Administration they are segmented into Oral, Parenteral and rectal.
By disease Type they are Gastroesophageal Reflux Disease, Inflammatory Bowel Disease and Other. And by End User Hospital Pharmacies, Retail Pharmacies and Other. Acid Neutralizers which are further sub segmented into Antacids, H2 antagonists, Proton pump inhibitors and others.
Key Players for Global Gastrointestinal Drugs Market:
AbbVie Inc. (US), AstraZeneca (UK), Johnson & Johnson (US), Valeant (US), Abbott Laboratories(US), Allergan Plc (US), Bayer AG (Germany), Janssen Biotech Inc. (US), Takeda Pharmaceutical Company Limited (Japan), Eisai Co., Ltd. (Japan), Valeant Pharmaceuticals (US), Sanofi (France), Janssen Biotech (US), GlaxoSmithKline Plc. (UK), Boehringer Ingelheim GmbH (Germany).
The report for Global Gastrointestinal Drugs Market Research Report of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
More Details with Brief TOC @ https://www.marketresearchfuture.com/reports/gastrointestinal-drugs-market-558
Gastrointestinal Drugs Market Regional Analysis:
North America, Europe, Asia Pacific and Middle East and Africa are the four major regional segment of global GI drugs market. North America account for the largest market share for the global gastrointestinal drug market. Increasing geriatric population is the major driving factor for the market of GI drugs in North America. Europe and Asia Pacific share nearly similar amount of market. Introduction of new drugs and different technology has increased the market in Asia Pacific and Europe. Asia Pacific is the most favourable region for the development of GI drug market. Huge population and infrastructural improvement has increases the scope for the development of this market in coming future.
Table of Contents for Global Gastrointestinal Drugs Market Research Report Forecast to 2023:
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 MARKET DYNAMICS
4 MARKET FACTOR ANALYSIS
5. GLOBAL GASTROINTESTINAL DRUGS MARKET, BY DRUG CATEGORY
6. GLOBAL GASTROINTESTINAL DRUGS MARKET, BY ROUTE OF ADMINISTRATION
7. GLOBAL GASTROINTESTINAL DRUGS MARKET, DISEASE TYPE
8 GLOBAL GASTROINTESTINAL DRUGS MARKET
9. GLOBAL GASTROINTESTINAL DRUGS MARKET, BY REGION
10. COMPETITIVE LANDSCAPE
11 COMPANY PROFILE
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/558
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastrointestinal Drugs Market Perceive Accruals USD 59.3 Billion – Avail at MRFR here
News-ID: 1312324 • Views: …
More Releases from Market Research Future
Cerebral Palsy Industry Projected to Reach USD 4.036 billion by 2035 with Steady …
The global healthcare sector continues to place increasing emphasis on neurological disorders that require long-term management and multidisciplinary care. Among these, cerebral palsy remains one of the most common childhood motor disabilities, affecting movement, posture, and muscle coordination. As awareness grows and treatment options continue to advance, the cerebral palsy industry is witnessing steady expansion driven by improved diagnosis, therapeutic innovation, and rising investments in rehabilitation services.
According to Market Research…
Reclaimed Lumber Market revenue expected to rise from USD 53.47 Billion in 2024 …
Based on the market research report from Market Research Future, here is a detailed overview of the global reclaimed lumber market. This sector is thriving at the intersection of environmental sustainability and distinctive design.
What is Reclaimed Lumber?
Reclaimed lumber is wood sourced from old structures like barns, factories, warehouses, and wine barrels, which is then processed and remilled for new use. It offers a unique combination of environmental benefits-reducing deforestation and…
Cardiovascular Information Systems Industry Expected to Reach USD 1,330.86 milli …
The global healthcare sector is undergoing a rapid digital transformation, particularly in specialized areas such as cardiovascular care where data accuracy, workflow efficiency, and real-time monitoring are critical. Cardiovascular Information Systems (CVIS) have emerged as essential platforms that integrate imaging, patient records, diagnostic data, and clinical workflows to support comprehensive cardiac care management.
According to Market Research Future (MRFR), the Cardiovascular Information System Market was valued at USD 640.0 million in…
Low E-Glass Industry forecast highlights robust 6.5% CAGR growth through 2035
Low-emissivity (Low-E) glass has a microscopically thin, transparent coating that reflects infrared energy (heat) while allowing visible light to pass through. This principle helps keep buildings warm in the winter by reflecting interior heat back inside, and cool in the summer by blocking exterior heat, all while reducing harmful UV rays.
The Global Low-E Glass Market: An Overview
The global Low-E glass market is on a strong growth trajectory, driven by the…
More Releases for Gastrointestinal
The Rising Prevalence Of Gastrointestinal Diseases And Its Impact On The Gastroi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Gastrointestinal Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the past few years, the market size of gastrointestinal devices has expanded significantly. The growth is set to continue, increasing from $11.11 billion in 2024 to $11.7 billion in 2025, which equates to a…
Prominent Gastrointestinal Pathogen Testing Market Trend for 2025: Advancements …
What combination of drivers is leading to accelerated growth in the gastrointestinal pathogen testing market?
The rise in foodborne diseases is expected to drive the growth of the gastrointestinal pathogen testing market. Foodborne diseases, caused by consuming contaminated food or drinks, are on the rise due to changes in food production and distribution, inadequate food safety measures, and climate change. Gastrointestinal pathogen testing helps identify pathogens responsible for foodborne illnesses, aiding…
Major Market Shift in Gastrointestinal Pathogen Testing Industry: Advancements I …
What Is the Forecasted Market Size and Growth Rate for the Gastrointestinal Pathogen Testing Market?
The market size for gastrointestinal pathogen testing has seen a consistent growth lately. Projected to surge from $4.05 billion in 2024 to $4.24 billion in 2025, it is expected to grow at a compound annual growth rate (CAGR) of 4.6%. The growth observed during the historic period can be ascribed to factors such as the amplified…
Gastrointestinal Bleeding Treatment Devices Market Report 2024 - Gastrointestina …
"The Business Research Company recently released a comprehensive report on the Global Gastrointestinal Bleeding Treatment Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free…
Gastrointestinal (GI) Stents Market is Driven by Rising Prevalence of Gastroint …
The Gastrointestinal (GI) Stents Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.
View Report - https://www.theinsightpartners.com/reports/gastrointestinal-gi-stents-market/
Gastrointestinal stents are used as an effective alternate to perform…
Gastrointestinal Devices Market Report 2018: Segmentation by Type (Gastrointesti …
Global Gastrointestinal Devices market research report provides company profile for Coloplast, Given Imaging, CONMED, Covidien, Ethicon, Olympus, Boston Scientific and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation…
